Vaxine Pty Ltd
10 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Randomised Controlled Phase 1 Study of Vaccine Therapy for Control or Cure of Chronic Hepatitis B Virus Infection (NCT03038802) | Vaxine Pty Ltd | 2026-03-01 |
| Covid-19 and Influenza Oral Vaccine Study (NCT06355232) | Vaxine Pty Ltd | 2024-05-01 |
| Autologous Tumour Vaccine Trial (NCT05807035) | Vaxine Pty Ltd | 2023-02-10 |
| Booster Study of SpikoGen COVID-19 Vaccine (NCT05542862) | Vaxine Pty Ltd | 2022-09-07 |
| A Phase 3b/4 Randomised Trial of 3 Doses of Protein-based Covid-19 Vaccine (SpikoGen) (NCT05279456) | Vaxine Pty Ltd | 2022-08-15 |
| Australian Phase 2b Study to Assess Effect of Dose Interval on Spikogen Covid-19 Vaccine (NCT05148871) | Vaxine Pty Ltd | 2022-03-01 |
| Monovalent Recombinant COVID19 Vaccine (NCT04453852) | Vaxine Pty Ltd | 2020-06-30 |
Track Vaxine Pty Ltd automatically
Every clearance here is in the API, with alerts when new ones post.